Berkeley Communications
HTA in the news
October 21 2026
Election 2026 Roundtable: The impact on health policy.
Chief Healthcare Executive
Our panel of experts analyzes the midterm elections. They look at changes in Congress and how federal spending could be affected.
Read more
October 21 2026
What Employers Should Measure Before Cutting GLP-1 Coverage
All.WorkSpace
Even as costs rise, employers have more options than covering GLP-1s broadly or dropping coverage. Better clinical information can help them make smarter decisions for their workforce.
Read more
October 21 2026
Midterms could give Democrats leverage on Medicaid cuts and ACA subsidies, policy experts say
Medical Economics
A former congressman and two health policy advocates expect shutdown standoffs to set the terms of any health care deal next year.
Read more
October 16 2026
Why America’s Healthcare System Rewards the Wrong Things | Ep 36
Growth Under Pressure Podcast
In this episode of Growth Under Pressure, Eric Josovitz sits down with Rob Andrews, former U.S. Congressman who served for nearly 24 years and helped pass the Affordable Care Act, to examine why America’s healthcare system rewards the volume of procedures rather than patient outcomes.
Listen now
October 15 2026
GLP-1 diabetes study: patients without gains often stay on drug
Human Resources Director America
A 12.7 million-patient analysis gives HR teams data for weight loss drug coverage reviews
Read more
October 14 2026
Which patients benefit most from GLP-1s?: 6 notes
RamaOnHealthcare
An Oct. 13 analysis from the Health Transformation Alliance examined linked claims and EHR data for 12.7 million patients from 2018 through 2025 to identify who is most and least likely to respond to GLP-1 therapy.
Read more
October 14 2026
Which patients benefit most from GLP-1s? 6 notes
Becker's Hospital Review
An Oct. 13 analysis from the Health Transformation Alliance examined linked claims and EHR data for 12.7 million patients from 2018 through 2025 to identify who is most and least likely to respond to GLP-1 therapy.
Read more
October 14 2026
GLP-1 patients who don’t respond stayed on therapy anyway, study finds
Insurance Business Magazine
New research gives benefits advisers more data to assess treatment outcomes, though long-term returns remain uncertain
Read more